5.36 USD
▼-0.03-7.43%
2026-08-03
市值
$7.83M
市盈率
—
EPS
-29.67
股息率
—
52 周区间
1.90 – 10.59
成交量
3.03K
Beta
1.02
目标价
—
52W 低 1.9052W 高 10.59
价格走势
公司简介
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States. It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of g...